Eledon Pharmaceuticals Q1 2026 Earnings EPS Misses Estimates as Company Continues Clinical Pipeline Development INSE Q1 2026 Earnings NarrowerThanExpected Loss Boosts Sentiment Despite Revenue Uncertainty LANDO Q1 2026 Earnings Preferred Dividend Coverage Remains Tight as EPS Beats Low Bar SOS Q3 2018 Earnings Significant EPS Miss Amidst Operational Challenges GPMT Q1 2026 Earnings Surprise EPS Beat Signals Operational Resilience MoonLake Immunotherapeutics MLTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline